newsfilter
← Latest News
PR Newswire·

Liminal BioSciences to Report Fourth Quarter and Year Ended 2022 Financial Results on March 15, 2023

LAVAL, QC, and CAMBRIDGE, England, March 13, 2023 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ:LMNL) ("Liminal BioSciences" or the "Company"), today announced that it plans to report its fourth quarter